Zepp Health PE Ratio 2017-2025 | ZEPP
Current and historical p/e ratio for Zepp Health (ZEPP) from 2017 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Zepp Health PE ratio as of June 12, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Zepp Health PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-06-12 | 2.39 | 0.00 | |
| 2025-03-31 | 2.96 | $-5.02 | 0.00 |
| 2024-12-31 | 2.60 | $-4.71 | 0.00 |
| 2024-09-30 | 4.35 | $-2.50 | 0.00 |
| 2024-06-30 | 2.40 | $-1.64 | 0.00 |
| 2024-03-31 | 4.08 | $-1.60 | 0.00 |
| 2023-12-31 | 5.68 | $-1.96 | 0.00 |
| 2023-09-30 | 4.60 | $-2.60 | 0.00 |
| 2023-06-30 | 4.56 | $-2.80 | 0.00 |
| 2023-03-31 | 5.24 | $-3.20 | 0.00 |
| 2022-12-31 | 5.80 | $-2.80 | 0.00 |
| 2022-09-30 | 5.48 | $-1.64 | 0.00 |
| 2022-06-30 | 7.40 | $-0.60 | 0.00 |
| 2022-03-31 | 11.52 | $0.04 | 288.00 |
| 2021-09-30 | 31.86 | $2.00 | 15.93 |
| 2021-06-30 | 46.58 | $2.28 | 20.43 |
| 2021-03-31 | 42.73 | $1.52 | 28.11 |
| 2020-12-31 | 47.01 | $2.08 | 22.60 |
| 2020-09-30 | 50.98 | $2.84 | 17.95 |
| 2020-06-30 | 49.03 | $3.88 | 12.64 |
| 2020-03-31 | 52.05 | $4.56 | 11.41 |
| 2019-12-31 | 47.69 | $5.12 | 9.31 |
| 2019-09-30 | 39.67 | $4.44 | 8.94 |
| 2019-06-30 | 39.67 | $3.72 | 10.66 |
| 2019-03-31 | 51.93 | $3.72 | 13.96 |
| 2018-12-31 | 39.00 | $3.12 | 12.50 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.036B | $0.183B |
| Zepp Health Corp. developed a platform of proprietary technology including AI chips, biometric sensors and health data algorithms, which drive a broadening line of smart health products for consumers and analytics services for insurers, healthcare providers, employers, drug and treatment companies. Zepp Health Corp., formerly known as Huami Corporation, is based in CUPERTINO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.946B | 59.99 |
| Hims & Hers Health (HIMS) | United States | $12.884B | 133.86 |
| Tempus AI (TEM) | United States | $12.253B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.705B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.914B | 61.16 |
| Privia Health (PRVA) | United States | $2.805B | 191.75 |
| Hinge Health (HNGE) | United States | $2.743B | 0.00 |
| Schrodinger (SDGR) | United States | $1.958B | 0.00 |
| Enovis (ENOV) | United States | $1.904B | 10.62 |
| Phreesia (PHR) | United States | $1.677B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.511B | 0.00 |
| Omnicell (OMCL) | United States | $1.424B | 25.12 |
| Azenta (AZTA) | United States | $1.410B | 65.55 |
| 10x Genomics (TXG) | United States | $1.327B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.661B | 0.00 |
| Claritev (CTEV) | United States | $0.646B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.623B | 0.00 |
| Talkspace (TALK) | United States | $0.518B | 154.75 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Standard BioTools (LAB) | United States | $0.410B | 0.00 |
| TruBridge (TBRG) | United States | $0.372B | 824.67 |
| Outset Medical (OM) | United States | $0.362B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.276B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.264B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.200B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
| Pulmonx (LUNG) | United States | $0.131B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.112B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.099B | 0.00 |
| CareCloud (CCLD) | United States | $0.095B | 3.61 |
| 111 (YI) | China | $0.064B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.027B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |